NURSING HOME VISITATION
The number of new COVID-19 cases in Ohio’s nursing homes has dropped significantly to 343 new cases last week compared to the peak of 2,832 new cases in December.
As the number of nursing-home cases continues to drop due to vaccinations in long-term facilities, Governor DeWine today reminded nursing home staff and families of nursing home residents about the status of visitation in Ohio’s nursing homes. Visitation is permitted at nursing homes in Ohio if the facilities meet the federal Centers for Medicare and Medicaid Services (CMS) criteria to allow visits:
- No new onset of COVID-19 cases in the last 14 days;
- The facility is not currently conducting outbreak testing; and
- CMS reports the COVID-19 county positivity rate at less than 10 percent.
Compassionate care visits, which are special visits in which a family member or other visitor provides comfort, support, and assistance to a resident whose well-being is suffering or at risk, are always permitted regardless of the criteria above.
Governor DeWine sent a letter today to all nursing homes in Ohio reminding them to check their county positivity rate every week to determine their visitation status and to remind them to allow for compassionate care visits.
Ohio’s nursing home facilities are required to report their visitation status to Ohio’s Long-Term Care Visitation Dashboard.
If you have a loved one in need of a compassionate care visit but are having trouble scheduling a visit, contact Ohio’s Office of the State Long-Term Care Ombudsman at OhioOmbudsman@age.ohio.gov or 1-800-282-1206.
PROGRESSION OF VACCINE ELIGIBILITY
Governor DeWine provided information on the progression of vaccine eligibility in Ohio. Because those ages 65 and older make up approximately 87 percent of all COVID-19 deaths in Ohio, no additional age groups are eligible for the vaccine at this time. Once the demand for the vaccine has been met for those 65 and older, those ages 60 and older will become eligible. After a period of vaccination for this age group, those ages 55 and older will become eligible, followed by those ages 50 and up.
Individuals in specific small groups that could have an increased risk of exposure to the virus may also potentially be included in the 60 and older vaccination phase.